Beyond glycemic control: the role of incretin hormones.
Ridge
Terry DeWayne
TD
American Health Network, Inc., Indianapolis, Indiana, USA.
D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism*; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions; D000077270:Exenatide; D052216:Glucagon-Like Peptide 1 / Q000378:metabolism*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014688:Venoms / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D052216:Glucagon-Like Peptide 1; D000077270:Exenatide